RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Phase Lib trial of tivantinib in combination with carboplatin and pernetrexed as first-line treatment in patients (pts) with advanced nonsquamous NSCLC or malignant pleural mesotheliorna (MPM)
2014-01-01 Zucali, Pa; Simonelli, M; De Vincenzo, F; Fatuzzo, G; Bertossl, M; Suter, Mb; Perrino, M; Giordano, L; Santoro, A
Preliminary results from phase Ib study of spartalizumab plus chemotherapy for advanced non-small cell lung cancer (NSCLC)
2020-01-01 Santoro, A.; Lopez, P. G.; Tan, D. S. W.; Paz-Ares, L.; Sheperd, F.; Bearz, A.; Barlesi, F.; Vansteenkiste, J. F.; Kim, T. M.; Overbeck, T. R.; Rybkin, I. I.; Felip, E.; Zhou, W.; Santarpia, L.; Eddy, S.; Shaefer, E. S.
Reliability of the HER2 status assessment by immunohistochemistry for breast cancer patients after preoperative chemotherapy
2006-01-01 Banna, Gl; Gulio, G; Masci, G; Simonelli, M; Rimassa, L; Di Tommaso, L; Bettio, D; Roncalli, M; Santoro, A
Retreatment with pemetrexed-based chemotherapy (PBC) in patients with malignant pleural mesothelioma (MPM): An observational study
2010-01-01 De Vincenzo, F; Zucali, P; Ceresoli, G; Gianoncelli, L; Lorenzi, E; Simonelli, M; Ripa, C; Giordano, L; Santoro, A
Retrospective analysis of an alternative immuno-score in clinical management of patients with pT2 urothelial carcinoma
2020-01-01 Colombo, Piergiuseppe; Zucali, Paolo Andrea; De Carlo, Camilla; Giordano, Laura; Hurle, Rodolfo; Lazzeri, Massimo; Elefante, Grazia Maria; D'Antonio, Federica; Regis, Federica; Guazzoni, Giorgio Ferruccio; Santoro, Armando; Roncalli, Massimo
Safety and efficacy of MET inhibitor tivantinib (ARQ 197) combined with sorafenib in patients (pts) with hepatocellular carcinoma (HCC) from a phase I study
2012-01-01 Martell, Re; Puzanov, I; Ma, Ww; Santoro, A; Dy, Gk; Goff, Lw; Fetterly, Gj; Michael, Sa; Means-Powell, Ja; Chai, F; Lamar, M; Simonelli, M; Chiang, Wm; Jarboe, J; Schwartz, Be; Adjei, Aa
Superiority of CHOI vs RECIST criteria in evaluating outcome of advanced soft tissue sarcoma (STS) patients treated with sorafenib
2012-01-01 De Sanctis, R; Bertuzzi, A; Magnoni, P; Giordano, L; Gasco, M; Lutman, R; Santoro, A
Supratotal resection in newly diagnosed GBMs: role of this surgical strategy beyond enhancing boundaries
2017-01-01 Pessina, F; Navarria, P; Cozzi, L; Simonelli, M; Santoro, A; Ascolese, Am; Clerici, E; Rossi, M; Scorsetti, M; Bello, L
The behavior of colorectal liver metastases in the time frame between the end of preoperative chemotherapy and liver resection: A new selection criterion for technically resectable patients
2017-01-01 Vigano, L; Darwish, Ss; Rimassa, L; Cimino, M; Carnaghi, C; Donadon, M; Procopio, F; Personeni, N; Del Fabbro, D; Santoro, A; Torzilli, G
The neural phenotype in invasive urothelial carcinoma patients: Alternative score detection and prognostic implication
2020-01-01 Zucali, Paolo Andrea; Colombo, Piergiuseppe; De Carlo, Camilla; Giordano, Laura; Hurle, Rodolfo; Lazzeri, Massimo; Elefante, Grazia Maria; D'Antonio, Federica; Regis, Federica; Perrino, Matteo; De Vincenzo, Fabio; Guazzoni, Giorgio Ferruccio; Roncalli, Massimo; Santoro, Armando
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Phase Lib trial of tivantinib in combination with carboplatin and pernetrexed as first-line treatment in patients (pts) with advanced nonsquamous NSCLC or malignant pleural mesotheliorna (MPM) | 1-gen-2014 | Zucali, Pa; Simonelli, M; De Vincenzo, F; Fatuzzo, G; Bertossl, M; Suter, Mb; Perrino, M; Giordano, L; Santoro, A | |
| Preliminary results from phase Ib study of spartalizumab plus chemotherapy for advanced non-small cell lung cancer (NSCLC) | 1-gen-2020 | Santoro, A.; Lopez, P. G.; Tan, D. S. W.; Paz-Ares, L.; Sheperd, F.; Bearz, A.; Barlesi, F.; Vansteenkiste, J. F.; Kim, T. M.; Overbeck, T. R.; Rybkin, I. I.; Felip, E.; Zhou, W.; Santarpia, L.; Eddy, S.; Shaefer, E. S. | |
| Reliability of the HER2 status assessment by immunohistochemistry for breast cancer patients after preoperative chemotherapy | 1-gen-2006 | Banna, Gl; Gulio, G; Masci, G; Simonelli, M; Rimassa, L; Di Tommaso, L; Bettio, D; Roncalli, M; Santoro, A | |
| Retreatment with pemetrexed-based chemotherapy (PBC) in patients with malignant pleural mesothelioma (MPM): An observational study | 1-gen-2010 | De Vincenzo, F; Zucali, P; Ceresoli, G; Gianoncelli, L; Lorenzi, E; Simonelli, M; Ripa, C; Giordano, L; Santoro, A | |
| Retrospective analysis of an alternative immuno-score in clinical management of patients with pT2 urothelial carcinoma | 1-gen-2020 | Colombo, Piergiuseppe; Zucali, Paolo Andrea; De Carlo, Camilla; Giordano, Laura; Hurle, Rodolfo; Lazzeri, Massimo; Elefante, Grazia Maria; D'Antonio, Federica; Regis, Federica; Guazzoni, Giorgio Ferruccio; Santoro, Armando; Roncalli, Massimo | |
| Safety and efficacy of MET inhibitor tivantinib (ARQ 197) combined with sorafenib in patients (pts) with hepatocellular carcinoma (HCC) from a phase I study | 1-gen-2012 | Martell, Re; Puzanov, I; Ma, Ww; Santoro, A; Dy, Gk; Goff, Lw; Fetterly, Gj; Michael, Sa; Means-Powell, Ja; Chai, F; Lamar, M; Simonelli, M; Chiang, Wm; Jarboe, J; Schwartz, Be; Adjei, Aa | |
| Superiority of CHOI vs RECIST criteria in evaluating outcome of advanced soft tissue sarcoma (STS) patients treated with sorafenib | 1-gen-2012 | De Sanctis, R; Bertuzzi, A; Magnoni, P; Giordano, L; Gasco, M; Lutman, R; Santoro, A | |
| Supratotal resection in newly diagnosed GBMs: role of this surgical strategy beyond enhancing boundaries | 1-gen-2017 | Pessina, F; Navarria, P; Cozzi, L; Simonelli, M; Santoro, A; Ascolese, Am; Clerici, E; Rossi, M; Scorsetti, M; Bello, L | |
| The behavior of colorectal liver metastases in the time frame between the end of preoperative chemotherapy and liver resection: A new selection criterion for technically resectable patients | 1-gen-2017 | Vigano, L; Darwish, Ss; Rimassa, L; Cimino, M; Carnaghi, C; Donadon, M; Procopio, F; Personeni, N; Del Fabbro, D; Santoro, A; Torzilli, G | |
| The neural phenotype in invasive urothelial carcinoma patients: Alternative score detection and prognostic implication | 1-gen-2020 | Zucali, Paolo Andrea; Colombo, Piergiuseppe; De Carlo, Camilla; Giordano, Laura; Hurle, Rodolfo; Lazzeri, Massimo; Elefante, Grazia Maria; D'Antonio, Federica; Regis, Federica; Perrino, Matteo; De Vincenzo, Fabio; Guazzoni, Giorgio Ferruccio; Roncalli, Massimo; Santoro, Armando |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 4 Contributo in Atti di Convegno ... 47
- 4 Contributo in Atti di Convegno ... 35
- 4 Contributo in Atti di Convegno ... 10
- 4 Contributo in Atti di Convegno ... 2
Data di pubblicazione
- 2020 - 2022 5
- 2010 - 2019 34
- 2005 - 2009 8
Rivista
- JOURNAL OF CLINICAL ONCOLOGY 19
- ANNALS OF ONCOLOGY 11
- EUROPEAN JOURNAL OF CANCER 2
- EUROPEAN JOURNAL OF CANCER. SUPPL... 2
- JOURNAL OF THORACIC ONCOLOGY 2
- CANCER RESEARCH 1
- EUROPEAN ASSOCIATION OF NEUROONCO... 1
- EUROPEAN JOURNAL OF NUCLEAR MEDIC... 1
- INTERNATIONAL JOURNAL OF RADIATIO... 1
- NEURO-ONCOLOGY 1
Lingua
- eng 7
- ita 1
Accesso al fulltext
- no fulltext 47